Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Intellia Thera CS
(NQ:
NTLA
)
14.81
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Nov 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Intellia Thera CS
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
You’ve Been Warned! 3 Gene Editing Stocks to Buy Now or Regret Forever.
June 27, 2024
The best gene editing stocks to buy are those with strong tehnogical applications and genuine commercialization prospects.
Via
InvestorPlace
Cathie Wood's Ark Invest Acquires $7.3M Worth Of Shares In This Promising Netflix Competitor, Sells Off Coinbase Stock Amid Bitcoin Slump
June 26, 2024
On Wednesday, Cathie Wood-led Ark Invest made significant trades in Roku Inc (NASDAQ:ROKU) and Coinbase Global Inc (NASDAQ:COIN), amidst a volatile market.
Via
Benzinga
3 Gene Editing Stocks That Could Make Your Grandchildren Rich
June 25, 2024
Explore gene-editing stocks with long-term growth potential, offering innovative solutions to previously untreatable conditions.
Via
InvestorPlace
Unveiling 6 Analyst Insights On Intellia Therapeutics
June 24, 2024
Via
Benzinga
RXO, Alnylam Pharmaceuticals And Other Big Stocks Moving Lower In Monday's Pre-Market Session
June 24, 2024
Via
Benzinga
Cracking The Code: Understanding Analyst Reviews For Intellia Therapeutics
June 04, 2024
Via
Benzinga
Why Intellia Therapeutics, Inc. Outpaced the Stock Market
May 05, 2024
Investors will be eagerly watching for the performance of Intellia Therapeutics, Inc. in its upcoming earnings disclosure.
Via
Talk Markets
2 Stocks Down 30% to Buy Right Now
April 14, 2024
These stocks have plenty of catalysts ahead.
Via
The Motley Fool
5 Biotech Stocks With Key Catalysts This Week: Merck, Intellia, Verona, And More
June 24, 2024
Biotech investing is risk-fraught but the returns could be staggering if one chooses to take the educated approach.
Via
Benzinga
Wall Street Favorites: 3 Cathie Wood Stocks With Strong Buy Ratings for June 2024
June 21, 2024
Investors looking for companies with high growth potential should consider investing in these three strong buy Cathie Wood stocks.
Via
InvestorPlace
Avidity Biosciences And CleanSpark Were Among The 10 Biggest Mid-Cap Stock Gainers Last Week (June 9-June 15): Are These In Your Portfolio?
June 16, 2024
Top mid-cap performers: Avidity Biosciences, Iris Energy, Hims & Hers Health, John Wiley & Sons, Element Solutions, CleanSpark, Enovix Corp, Axcelis Tech, Intellia Therapeutics, Korn Ferry.
Via
Benzinga
Cathie Wood-Lead Ark Invest Dumps $7.6M Worth Of Robinhood Shares Amid GameStop Buzz, Bitcoin Choppiness
June 10, 2024
On Monday, Cathie Wood-led Ark Invest made a significant move by reducing its holdings in Robinhood Markets Inc (NASDAQ:HOOD). This decision came amidst a period of market fluctuations and followed a...
Via
Benzinga
Cathie Wood Goes Bargain Hunting: 2 Stocks She Just Bought
June 09, 2024
These companies could generate explosive growth over time.
Via
The Motley Fool
These 2 Words Are Why Intellia Therapeutics Could Be a Smart Buy Right Now
June 08, 2024
Neither word has anything to do with money -- at least not yet.
Via
The Motley Fool
Cathie Wood-Led Ark Invest Buys $9.9M Worth Of Amazon Shares, Also Picks Up Reddit Stock
June 06, 2024
Via
Benzinga
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
June 06, 2024
The widely followed growth investor made big moves as May came to a close.
Via
The Motley Fool
The 3 Best Biotech Stocks to Buy in June 2024
June 05, 2024
Explore the best biotech stocks to buy in June 2024, with insights on Protagonist, BridgeBio and Intellia.
Via
InvestorPlace
Cathie Wood Is Buying the Dip on These 2 Biotech Stocks. Should You?
June 04, 2024
In keeping with Cathie Wood's style, these picks are riskier than average.
Via
The Motley Fool
Why Intellia Therapeutics Shares Are Trading Higher Monday
June 03, 2024
Intellia's NTLA-2002 is an experimental CRISPR based gene-editing therapy being developed as a one-time treatment for hereditary angioedema (HAE). The company announced the single does treatment led to...
Via
Benzinga
Stericycle, MarineMax, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Monday
June 03, 2024
Via
Benzinga
Cathie Wood-Led Ark Invest Sells Nearly $28M Worth Of Robinhood Shares Amid Crypto API Launch And Lackluster Bitcoin Price Action
May 30, 2024
On Thursday, Cathie Wood-led Ark Invest made notable adjustments to its portfolio, including a significant sell-off of Robinhood Markets Inc (NASDAQ:HOOD) shares.
Via
Benzinga
Cathie Wood's Ark Innovation ETF Sees Sharp Decline Among Top Holdings — Here Are 10-Largest Losers Within ARKF
May 28, 2024
Cathie Wood's flagship ARK Innovation ETF has been navigating through significant losses, showcasing the challenges faced by some of its major holdings.
Via
Benzinga
Topics
ETFs
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
May 22, 2024
The popular growth investor keeps adding to some of her favorite falling stocks.
Via
The Motley Fool
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
May 10, 2024
The popular growth investor bought into one of Thursday's biggest losers and two stocks that have fallen sharply over the past year.
Via
The Motley Fool
NTLA Stock Earnings: Intellia Therapeutics Beats EPS, Beats Revenue for Q1 2024
May 09, 2024
NTLA stock results show that Intellia Therapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Just Say No to Drugs: 3 Pharma Stocks to Avoid
May 08, 2024
Discover which pharma stocks to avoid in 2023 as we delve into market trends, financial struggles, and the impact on investor portfolios.
Via
InvestorPlace
Shhh! 3 Secret Gene Editing Stocks Flying Below Wall Street’s Radar
May 03, 2024
The gene editing stocks are worth tuning into as some investors out there discount their innovative, albeit early-stage pipelines.
Via
InvestorPlace
3 Gene Editing Stocks with the Potential to Make You an Overnight Millionaire
May 02, 2024
Pay close attention to gene editing stocks. By 2028, according to MarketsandMarkets, the market could be worth about $10.6 billion.
Via
InvestorPlace
Cathie Wood Goes Bargain Hunting. 2 Stocks She Bought This Week.
April 12, 2024
These two stocks could be ripe for a rebound.
Via
The Motley Fool
Bull Market and Beyond: 3 Stocks Just Waiting to Soar
April 09, 2024
These stocks, a bargain today, are players to hold on to for the long term.
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.